SCHEMBL9733076

SCHEMBL9733076

NCCN1CCN(CC=Cc2ccccc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.61
TDP1 Q9NUW8 4/20 0.61
CYP1A2 P05177 4/20 0.61
CYP2D6 P10635 4/20 0.61
CYP2C9 P11712 4/20 0.61
TP53 P04637 2/20 0.61
TSHR P16473 2/20 0.61
CYP2C19 P33261 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
SIGMAR1 Q99720 4/20 0.59
CYP3A4 P08684 4/20 0.59
LMNA P02545 3/20 0.59
HIF1A Q16665 3/20 0.59
ALDH1A1 P00352 3/20 0.59
OPRM1 P35372 2/20 0.59
OPRK1 P41145 2/20 0.59
GMNN O75496 1/20 0.59
ABCB11 O95342 1/20 0.59
CHRM2 P08172 1/20 0.59
CHRM4 P08173 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9733074 1.00 MAPK1 (0.61) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL2579539 0.88 LMNA (0.72) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL11387099 0.83 TDP1 (0.61) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL9646805 0.83 TDP1 (0.61) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL11387103 0.83 TDP1 (0.61) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL9646816 0.83 TDP1 (0.61) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL5961390 0.83 SIGMAR1 (0.75) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL7261524 0.83 LMNA (0.62) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL28015193 0.83 LMNA (0.62) MAPK1TDP1CYP1A2CYP2D6CYP2C9
SCHEMBL11403894 0.81 HRH3 (0.61) MAPK1TDP1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5164391-A Treatment of diabetes and circulatory disorders, aldose reductase inhibitor SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1992-11-17 US disclosed
EP-0418834-A1 Hydantoin derivatives for treating complications of diabetes and circulatory diseases SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1991-03-27 EP disclosed